Effects of intra-articular ketamine on pain and somatosensory function in temporomandibular joint arthralgia patients

Pain

Volumn 137, Issue 2, 2008, Pages 286-294

  Ayesh, Emad E ^a   Jensen, Troels S ^b   Svensson, Peter ^a,b,c  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY   (Denmark)

Author keywords

Arthralgia; Ketamine; NMDA; Quantitative sensory tests; TMJ pain; Trigeminal physiology

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PLACEBO; SODIUM CHLORIDE;

ABSENCE OF SIDE EFFECTS; ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; JAW; MALE; MYOFASCIAL PAIN; NOCICEPTION; NOCICEPTIVE RECEPTOR; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORIMOTOR FUNCTION; SENSORY ANALYSIS; SOMATOSENSORY SYSTEM; TACTILE DISCRIMINATION; TEMPOROMANDIBULAR JOINT; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADULT; AFFERENT PATHWAYS; ANALGESICS; ARTHRALGIA; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; KETAMINE; MALE; NOCICEPTORS; PAIN MEASUREMENT; PAIN THRESHOLD; PLACEBOS; PROPRIOCEPTION; RECEPTORS, N-METHYL-D-ASPARTATE; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDERS; TREATMENT FAILURE; TRIGEMINAL NERVE;

EID: 45549090951     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2007.09.004     Document Type: Article

References (73)

1. Alfredson H., Forsgren S., Thorsen K., and Lorentzon R. In vivo microdialysis and immunohistochemical analyses of tendon tissue demonstrated high amounts of free glutamate and glutamate NMDAR1 receptors, but no signs of inflammation, in Jumper's knee. J Orthop Res 19 (2001) 881-886
2. Alfredson H., Forsgren S., Thorsen K., Fahlstrom M., Johansson H., and Lorentzon R. Glutamate NMDAR1 receptors localised to nerves in human Achilles tendons. Implications for treatment?. Knee Surg Sports Traumatol Arthrosc 9 (2001) 123-126
3. Arendt-Nielsen L., Petersen-Felix S., Fischer M., Bak P., Bjerring P., and Zbinden A.M. The effect of N-methyl-d-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli: a placebo-controlled experimental human study. Anesth Analg 81 (1995) 63-68
4. Arendt-Nielsen L., Nielsen J., Petersen-Felix S., Schnider T.W., and Zbinden A.M. Effect of racemic mixture and the (S+)-isomer of ketamine on temporal and spatial summation of pain. Br J Anaesth 77 (1996) 625-631
5. Ayesh E.E., Jensen T.S., and Svensson P. Somatosensory function following painful repetitive electrical stimulation of the human temporomandibular joint and skin. Exp Brain Res 179 (2007) 415-425
6. Ayesh E.E., Ernberg M., and Svensson P. Effects of local anesthetics on somatosensory function in the temporomandibular joint area. Exp Brain Res 180 (2007) 715-725
7. Ayesh EE, Jensen TS, Svensson P. Hypersensitivity in painful temporomandibular joint patients. J Dent Res 2007; in press.
8. Baad-Hansen L., Juhl G.I., Jensen T.S., Brandsborg B., and Svensson P. Differential effect of intravenous S-ketamine and fentanyl on atypical odontalgia and capsaicin-evoked pain. Pain 129 (2007) 46-54
9. Batra Y.K., Mahajan R., Bangalia S.K., Nagi O.N., and Dhillon M.S. Bupivacaine/ketamine is superior to intra-articular ketamine analgesia following arthroscopic knee surgery. Can J Anaesth 52 (2005) 832-836
10. Berger U.V., Carter R.E., and Coyle J.T. The immunocytochemical localization of N-acetylaspartyl glutamate, its hydrolysing enzyme NAALADase, and the NMDAR-1 receptor at a vertebrate neuromuscular junction. Neuroscience 64 (1995) 847-850
11. Bristow A., and Orlikowski C. Subcutaneous ketamine analgesia: postoperative analgesia using subcutaneous infusions of ketamine and morphine. Ann R Coll Surg Engl 71 (1989) 64-66
12. Cairns B.E., Sessle B.J., and Hu J.W. Evidence that excitatory amino acid receptors within the temporomandibular joint region are involved in the reflex activation of the jaw muscles. J Neurosci 18 (1998) 8056-8064
13. Cairns B.E., Gambarota G., Svensson P., Arendt-Nielsen L., and Berde C.B. Glutamate-induced sensitization of rat masseter muscle fibers. Neuroscience 109 (2002) 389-399
14. Cairns B.E., Svensson P., Wang K., Hupfeld S., Graven-Nielsen T., Sessle B.J., et al. Activation of peripheral NMDA receptors contributes to human pain and rat afferent discharges evoked by injection of glutamate into the masseter muscle. J Neurophysiol 90 (2003) 2098-2105
15. Cairns B.E., Svensson P., Wang K., Castrillon E., Hupfeld S., Sessle B.J., et al. Ketamine attenuates glutamate-induced mechanical sensitization of the masseter muscle in human males. Exp Brain Res 169 (2006) 467-472
16. Cairns B.E. The influence of gender and sex steroids on craniofacial nociception. Headache 47 (2007) 319-324
17. Carlton SM, McNearney TA, Cairns BE. Peripheral glutamate receptors: Novel targets for Analgesics? In: Dostrovsky JO et al., editor. Proceedings of the 10th world congress on pain, progress in pain research and management. Seattle: IASP Press, 2003. pp. 125-139.
18. Carlton S.M., Hargett G.L., and Coggeshall R.E. Localization and activation of glutamate receptors in unmyelinated axons of rat glabrous skin. Neurosci Lett 197 (1995) 25-28
19. Carlton S.M., and Coggeshall R.E. Inflammation-induced changes in peripheral glutamate receptor populations. Brain Res 820 (1999) 63-70
20. Castrillon E.E., Cairns B.E., Ernberg M., Wang K., Sessle B.J., Arendt-Nielsen L., and Svensson P. Effect of a peripheral NMDA receptor antagonist on glutamate-evoked masseter muscle pain and mechanical sensitization in women. J Orofac Pain 21 (2007) 216-224
21. Chen J.J., and Johnson E.J. Targeting the bradykinin B1 receptor to reduce pain. Expert Opin Ther Targets 11 (2007) 21-35
22. Curatolo M., Petersen-Felix S., and Arendt-Nielsen L. Sensory assessment of regional analgesia in humans: a review of methods and applications. Anesthesiology 93 (2000) 1517-1530
23. Dal D., Tetik O., Altunkaya H., Tetik O., and Doral M.N. The efficacy of intra-articular ketamine for postoperative analgesia in outpatient arthroscopic surgery. Arthroscopy 20 (2004) 300-305
24. Dong X.D., Mann M.K., Sessle B.J., Arendt-Nielsen L., Svensson P., and Cairns B.E. Sensitivity of rat temporalis muscle afferent fibers to peripheral N-methyl-d-aspartate receptor activation. Neuroscience 141 (2006) 939-945
25. Dworkin S.F., and LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord 6 (1992) 301-355
26. Finnerup N.B., and Jensen T.S. Mechanisms of disease: mechanism-based classification of neuropathic pain-a critical analysis. Nat Clin Pract Neurol 2 (2006) 107-115
27. Fiorentino P.M., Cairns B.E., and Hu J.W. Development of inflammation after application of mustard oil or glutamate to the rat temporomandibular joint. Arch Oral Biol 44 (1999) 27-32
28. Frenkel C., and Urban B.W. Molecular actions of racemic ketamine on human CNS sodium channels. Br J Anaesth 69 (1992) 292-297
29. Gammaitoni A., Gallagher R.M., and Welz-Bosna M. Topical ketamine gel: possible role in treating neuropathic pain. Pain Med 1 (2000) 97-100
30. Gazerani P., Wang K., Cairns B.E., Svensson P., and Arendt-Nielsen L. Effects of subcutaneous administration of glutamate on pain, sensitization and vasomotor responses in healthy men and women. Pain 124 (2006) 338-348
31. Gottrup H., Bach F.W., and Jensen T.S. Differential effects of peripheral ketamine and lidocaine on skin flux and hyperalgesia induced by intradermal capsaicin in humans. Clin Physiol Funct Imaging 24 (2004) 103-108
32. Graven-Nielsen T., Aspegren K.S., Henriksson K.G., Bengtsson M., Sorensen J., Johnson A., et al. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 85 (2000) 483-491
33. Hill R.G., and Oliver K.R. Neuropeptide and kinin antagonists. Handb Exp Pharmacol (2007) 181-216
34. Huang G.S., Yeh C.C., Kong S.S., Lin T.C., Ho S.T., and Wong C.S. Intra-articular ketamine for pain control following arthroscopic knee surgery. Acta Anaesthesiol Sin 38 (2000) 131-136
35. Islas J.A., Astorga J., and Laredo M. Epidural ketamine for control of postoperative pain. Anesth Analg 64 (1985) 1161-1162
36. Jensen T.S., Gottrup H., Kasch H., Nikolajsen L., Terkelsen A.J., and Witting N. Has basic research contributed to chronic pain treatment?. Acta Anaesthesiol Scand 45 (2001) 1128-1135
37. Jensen T.S., and Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain 102 (2003) 1-8
38. Kim H.K., Schattschneider J., Lee I., Chung K., Baron R., and Chung J.M. Prolonged maintenance of capsaicin-induced hyperalgesia by brief daily vibration stimuli. Pain 129 (2007) 93-101
39. Klein T., Magerl W., Nickel U., Hopf H.C., SandkÃ1/4hler J., and Treede R.D. Effects of the NMDA-receptor antagonist ketamine on perceptual correlates of long-term potentiation within the nociceptive system. Neuropharmacology 52 (2007) 655-661
40. Kristensen J.D., Svensson B., and Gordh Jr. T. The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain 51 (1992) 249-253
41. Lam D.K., Sessle B.J., Cairns B.E., and Hu J.W. Neural mechanisms of temporomandibular joint and masticatory muscle pain: a possible role for peripheral glutamate receptor mechanisms. Pain Res Manag 10 (2005) 145-152
42. Lam D.K., Sessle B.J., Cairns B.E., and Hu J.W. Peripheral NMDA receptor modulation of jaw muscle electromyographic activity induced by capsaicin injection into the temporomandibular joint of rats. Brain Res 1046 (2005) 68-76
43. Lawand N.B., McNearney T., and Westlund K.N. Amino acid release into the knee joint: key role in nociception and inflammation. Pain 86 (2000) 69-74
44. List T., and Dworkin S.F. Comparing TMD diagnoses and clinical findings at Swedish and US TMD centers using research diagnostic criteria for temporomandibular disorders. J Orofac Pain 10 (1996) 240-253
45. List T., Axelsson S., and Leijon G. Pharmacologic interventions in the treatment of temporomandibular disorders, atypical facial pain, and burning mouth syndrome. A qualitative systematic review. J Orofac Pain 17 (2003) 301-310
46. Lobbezoo F., Drangsholt M., Peck C., Sato H., Kopp S., and Svensson P. Topical review: new insights into the pathology and diagnosis of disorders of the temporomandibular joint. J Orofac Pain 18 (2004) 181-191
47. Mathisen L.C., Skjelbred P., Skoglund L.A., and Oye I. Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain 61 (1995) 215-220
48. Maixner W., Fillingim R., Booker D., and Sigurdsson A. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain. Pain 63 (1995) 341-351
49. Maixner W., Fillingim R., Sigurdsson A., Kincaid S., and Silva S. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: evidence for altered temporal summation of pain. Pain 76 (1998) 71-81
50. McNearney T., Speegle D., Lawand N., Lisse J., and Westlund K.N. Excitatory amino acid profiles of synovial fluid from patients with arthritis. J Rheumatol 27 (2000) 739-745
51. McNearney T., Baethge B.A., Cao S., Alam R., Lisse J.R., and Westlund K.N. Excitatory amino acids, TNF-alpha, and chemokine levels in synovial fluids of patients with active arthropathies. Clin Exp Immunol 137 (2004) 621-627
52. McRoberts J.A., Coutinho S.V., Marvizon J.C., Grady E.F., Tognetto M., Sengupta J.N., et al. Role of peripheral N-methyl-d-aspartate (NMDA) receptors in visceral nociception in rats. Gastroenterology 120 (2001) 1737-1748
53. Menigaux C., Fletcher D., Dupont X., Guignard B., Guirimand F., and Chauvin M. The benefits of intraoperative small-dose ketamine on postoperative pain after anterior cruciate ligament repair. Anesth Analg 90 (2000) 129-135
54. Menigaux C., Guignard B., Fletcher D., Sessler D.I., Dupont X., and Chauvin M. Intraoperative small-dose ketamine enhances analgesia after outpatient knee arthroscopy. Anesth Analg 93 (2001) 606-612
55. Poyhia R., and Vainio A. Topically administered ketamine reduces capsaicin-evoked mechanical hyperalgesia. Clin J Pain 22 (2006) 32-36
56. Rabben T., Skjelbred P., and Oye I. Prolonged analgesic effect of ketamine, an N-methyl-d-aspartate receptor inhibitor, in patients with chronic pain. J Pharmacol Exp Ther 289 (1999) 1060-1066
57. Rabben T., and Oye I. Interindividual differences in the analgesic response to ketamine in chronic orofacial pain. Eur J Pain 5 (2001) 233-240
58. Rosseland L.A., Stubhaug A., Sandberg L., and Breivik H. Intra-articular (IA) catheter administration of postoperative analgesics. A new trial design allows evaluation of baseline pain, demonstrates large variation in need of analgesics, and finds no analgesic effect of IA ketamine compared with IA saline. Pain 104 (2003) 25-34
59. Sahara Y., Noro N., Iida Y., Soma K., and Nakamura Y. Glutamate receptor subunits GluR5 and KA-2 are coexpressed in rat trigeminal ganglion neurons. J Neurosci 17 (1997) 6611-6620
60. Sato K., Kiyama H., Park H.T., and Tohyama M. AMPA, KA and NMDA receptors are expressed in the rat DRG neurones. Neuroreport 4 (1993) 1263-1265
61. Schaible H.G., Schmelz M., and Tegeder I. Pathophysiology and treatment of pain in joint disease. Adv Drug Deliv Rev 58 (2006) 323-342
62. Schnoebel R., Wolff M., Peters S.C., Brau M.E., Scholz A., Hempelmann G., et al. Ketamine impairs excitability in superficial dorsal horn neurones by blocking sodium and voltage-gated potassium currents. Br J Pharmacol 146 (2005) 826-833
63. Schulte H., Graven-Nielsen T., Sollevi A., Jansson Y., Arendt-Nielsen L., and Segerdahl M. Pharmacological modulation of experimental phasic and tonic muscle pain by morphine, alfentanil and ketamine in healthy volunteers. Acta Anaesthesiol Scand 47 (2003) 1020-1030
64. Steenland H.W., Ko S.W., Wu L.J., and Zhuo M. Hot receptors in the brain. Mol Pain 2 (2006) 34
65. Svensson P., Graven-Nielsen T., and Arendt-Nielsen L. Mechanical hyperesthesia of human facial skin induced by tonic painful stimulation of jaw muscles. Pain 74 (1998) 93-100
66. Vranken J.H., Troost D., de H.P., Pennings F.A., vand V., Dijkgraaf M.G., et al. Severe toxic damage to the rabbit spinal cord after intrathecal administration of preservative-free S(+)-ketamine. Anesthesiology 105 (2006) 813-818
67. Wallace M.S. Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain. Expert Rev Neurother 6 (2006) 1423-1428
68. Warncke T., Jorum E., and Stubhaug A. Local treatment with the N-methyl-d-aspartate receptor antagonist ketamine, inhibit development of secondary hyperalgesia in man by a peripheral action. Neurosci Lett 227 (1997) 1-4
69. Wood J.N. Ion channels in analgesia research. Handb Exp Pharmacol (2007) 329-358
70. Xu M., Kim C.J., Neubert M.J., and Heinricher M.M. NMDA receptor-mediated activation of medullary pro-nociceptive neurons is required for secondary thermal hyperalgesia. Pain 127 (2007) 253-262
71. Yap A.U., Dworkin S.F., Chua E.K., List T., Tan K.B., and Tan H.H. Prevalence of temporomandibular disorder subtypes, psychologic distress, and psychosocial dysfunction in Asian patients. J Orofac Pain 17 (2003) 21-28
72. Yu X.M., Sessle B.J., Haas D.A., Izzo A., Vernon H., and Hu J.W. Involvement of NMDA receptor mechanisms in jaw electromyographic activity and plasma extravasation induced by inflammatory irritant application to temporomandibular joint region of rats. Pain 68 (1996) 169-178
73. Zapantis G., Csoka I., Csanyi E., Horvath G., and Eros I. Evaluation of ketamine systemic absorption from topical preparations. Short Communnication. Acta Biol Hung 57 (2006) 387-389